Common Stock SEC Reporting - Current
Verified Company Profile 8/02/2016
Contact Info
  • 6320 Canoga Avenue
  • 15th Floor
  • Woodland Hills, CA 91367

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001528172
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2008
Employees 16 a/o Nov 13, 2012
Company Officers/Contacts
Alan Collier CEO, Interim CFO
Michael Mann President
Don Calabria COO
Steven Barnes VP, Investor Rel.
Leonard Makowka Chief Med. Officer
Company Directors
Alan Collier Chairman
Company Notes
  • Formerly=Hanover Portfolio Acquisitions Inc. until 5-2014
Service Providers
Accounting/Auditing Firm
Rose, Snyder & Jacobs
15821 Ventura Blvd.
Suite 490
Encino, 91436
United States

Legal Counsel
Frank J. Hariton, Esq.
1065 Dobbs Ferry Road
White Plains, NY, 10607
United States

Investor Relations Firm
Not Available
ENDV Security Details
Share Structure
Market Value1 $13,536,254 a/o Oct 21, 2016
Authorized Shares 250,000,000 a/o May 18, 2015
Outstanding Shares 122,945,087 a/o Aug 11, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 622,092 a/o May 18, 2015
Par Value Not Available
Transfer Agent(s)
ClearTrust, LLC
Shareholders of Record 317 a/o May 17, 2016
Short Selling Data
Short Interest 726 (-90.1%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security